EN PL
REVIEW PAPER
Role of histamine in rheumatoid diseases
 
More details
Hide details
 
Online publication date: 2010-04-09
 
 
Reumatologia 2010;48(1):49-53
 
KEYWORDS
ABSTRACT
The pathogenesis of rheumatic diseases is still not fully explained but it is known that the balance between cytokines and inflammatory mediators plays a critical role in regulating the ongoing pathological process. Histamine, an endogenous amine, participates in the pathogenesis of rheumatic diseases in the early phase of inflammation as well as in its chronic stage. Increased concentration of histamine in the inflamed tissues and in blood is observed. Expression of the four types of histamine receptors in joint tissues reflects histamine involvement in the course of cartilage destruction. In this review we discuss the role of histamine in pathogenesis of rheumatoid arthritis, osteoarthritis and osteoporosis.
 
REFERENCES (45)
1.
Nigrovic PA, Lee DM. Mast cells in inflammatory arthritis. Arthritis Res Ther 2005; 7: 1-11.  .
 
2.
Jakubicz D, Maśliński S. Komórka tuczna w stawie. Część I. Morfologia, fizjologia i lokalizacja komórki tucznej w tkankach. Reumatologia 1996; 34: 31-38.  .
 
3.
Woolley DE, Tetlow LC. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res 2000; 2: 65-74.  .
 
4.
Maślińska D, Gajewski M, Maśliński S. Drobnocząsteczkowe mediatory zapalenia. Medycyna po Dyplomie 2008; 10: 19-23.  .
 
5.
Weissler A, Mekori YA, Mor A. The role of mast cells in non-allergic inflammation. IMAJ 2008; 10: 843-845.  .
 
6.
Baraniuk JN. Alergiczny nieżyt nosa – współczesne poglądy na patofizjologię. Alergia Astma Immunologia 1998; 3: 3-11.  .
 
7.
Alam R, Kumar D, Anderson-Walters D, Forsythe PA. Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 1994; 152: 1298-1303.  .
 
8.
Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-αlpha. Nature 1996; 381: 77-80.  .
 
9.
Wang HW, Tedla N, Lloyd AR, et al. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 1998; 102: 1617-1626. 10. Sayed BA, Brown MA. Mast cells as modulators of T-cell responses. Immunol Rev 2007; 217: 53-64. .
 
10.
Szeberényi JB, László V, Pállinger E, et al. Intracellular histamine content increases during in vitro dendritic cell differentiation. Inflamm Res 2001; 50 Suppl 2: 112-113. .
 
11.
Maśliński S. Mediatory zapalenia. Ultrasonografia 2009; 9: 9-13. .
 
12.
Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990; 42: 45-83. .
 
13.
Rimmer SJ, Church MK. The pharmacology and mechanisms of action of histamine H1-antagonists. Clin Exp Allergy 1990; 20 Suppl 2: 3-17. .
 
14.
Carewicz R, Płusa T. Leki przeciwhistaminowe w terapii astmy oskrzelowej. Przew Lek 2000; 5: 60-68. .
 
15.
Gantner F, Sakai K, Tusche MW, et al. Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells. J Pharmacol Exp Ther 2002; 303: 300-307. .
 
16.
Bissonnette EY. Histamine inhibits tumor necrosis factor alpha release by mast cells through H2 and H3 receptors. Am J Respir Cell Mol Biol 1996; 14: 620-626. .
 
17.
Morisset S, Rouleau A, Ligneau X, et al. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 2000; 408: 860-864. .
 
18.
Silver RB, Poonwasi KS, Seyedi N, et al. Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings. Proc Natl Acad Sci U S A 2002; 99: 501-506. .
 
19.
Silver RB, Mackins CJ, Smith NC, et al. Coupling of histamine H3 receptors to neuronal Na+/H+ exchange: a novel protective mechanism in myocardial ischemia. Proc Natl Acad Sci U S A 2001; 98: 2855-2859. .
 
20.
Thurmond RL, Desai PJ, Dunford PJ, et al. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 2004; 309: 404-413. .
 
21.
Gutzmer R, Diestel C, Mommert S, et al. Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Im-munol 2005; 174: 5224-5232. .
 
22.
Malone DG, Irani AM, Schwartz LB, et al. Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 1986; 29: 956-693. .
 
23.
Buckley MG, Walters C, Wong WM, et al. Mast cell activation in arthritis: detection of alpha- and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci 1997; 93: 363-370. .
 
24.
Renoux M, Hilliquin P, Galoppin L, et al. Cellular activation products in osteoarthritis synovial fluid. Int J Clin Pharmacol Res 1995; 15: 135-138. .
 
25.
Taylor DJ, Woolley DE. Evidence for both histamine H-1 and H-2 receptors on human articular chondrocytes. Ann Rheum Dis 1987; 46: 431-435. .
 
26.
Tetlow LC, Woolley DE. Histamine stimulates the proliferation of human articular chondrocytes in vitro and is expressed by chondrocytes in osteoarthritic cartilage. Ann Rheum Dis 2003; 62: 991-994. .
 
27.
Tetlow LC, Woolley DE. Histamine, histamine receptors H1 and H2, and histamine decarboxylase expression by chondrocytes of osteoarthritic cartilage: an immunohistochemikal study. Rheumatol Int 2005; 26: 173-178. .
 
28.
Tetlow LC, Woolley DE. Histamine stimulates matrix metalloproteinase-3 and -13 production by human articular chondrocytes in vitro. Ann Rheum Dis 2002; 61: 737-740. .
 
29.
Kohka H, Nishibori M, Iwagaki H, et al. Histamine is a potent inducer of IL-18 and IFN-gamma in human peripheral blood mononuclear cells. J Immunol 2000; 164: 6640-6646. .
 
30.
Nakamura T, Itadani H, Hidaka Y, et al. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000; 279: 615-620. .
 
31.
Takeshita K, Sakai K, Bacon KB, Gantner F. Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J Pharmacol Exp Ther 2003; 307: 1072-1078. .
 
32.
Gutzmer R, Diestel C, Mommert S, et al. Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol 2005; 174: 5224-5232. .
 
33.
Kaliński P, Hilkens CM, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999; 20: 561-567. .
 
34.
Morgan RK, McAllister B, Cross L, et al. Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. J Immunol 2007; 178: 8081-8089. .
 
35.
Grzybowska-Kowalczyk A, Wojtecka-Lukasik E, Maślińska D, et al. Distribution pattern of histamine H4 receptor in human synovial tissue from patients with rheumatoid arthritis. Inflamm Res 2007; 56, Suppl 1: 59-60. .
 
36.
Maślińska D, Opertowska J, Chabros W, et al. Histamine releasing factor (HRF) in pannus of joints affected by rheumatoid arthritis. Inflamm Res 2008; 57, Suppl 1: 61-62. .
 
37.
Zenmyo M, Hiraoka K, Komiya S, et al. Histamine-stimulated production of matrix metalloproteinase 1 by human rheumatoid synovial fibroblasts is mediated by histamine H1-receptors. Virchows Arch 1995; 427: 437-444. .
 
38.
Tanaka S, Sohen S, Fukuda K. A role for histamine receptors in rheumatoid arthritis. Semin Arthritis Rheum 1997; 26: 824-833. .
 
39.
Wojtecka-Łukasik E, Filipowicz-Sosnowska A, Zubrzycka-Sienkiewicz A i wsp. Aktywność kolagenozy leukocytów obojętnochłonnych w osoczu chorych na aktywne reumatoidalne zapalenie stawów powikłane zapaleniem naczyń lub amyloidozą. Reumatologia 1993; 31: 160-168. .
 
40.
Wize J, Wojtecka-Łukasik E, Maśliński S. Collagen-derived peptides relase mast cell histamine. Agents Actions 1986; 18: 262-265. .
 
41.
Wojtecka-Łukasik E, Maśliński S. Fibronectin and fibrynogen degradation products stimulate PMN-leukocyte and mast cell degranulation. J Physiol Pharmacol 1992; 4: 173-181. .
 
42.
Gujski M, Wojtecka-Łukasik E, Gajewski M, et al. Is lymphocyte histamine involved in the pathogenesis of rheumatoid arthritis. Inflamm Res 2000; 49, Suppl 1: 25-26. .
 
43.
Wojtecka-Łukasik E, Maśliński S. Histamine, 5-hydroxytryptamine and compound 48/80 activate PMN- leukocyte collagenase of the rat. Agents Actions 1984; 14: 451-453. .
 
44.
Ikawa Y, Yonekawa T, Ohkuni Y, et al. A comparative study of histamine activities on differentiation of osteoblasts and osteoclasts. J Toxicol Sci 2007; 32: 555-564. .
 
45.
Yamaura K, Yonekawa T, Nakamura T, et al. The histamine H2-receptor antagonist, cimetidine, inhibits the articular osteopenia in rats with adjuvant-induced arthritis by suppressing the osteoclast differentiation induced by histamine. J Pharmacol Sci 2003; 92: 43-49.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top